WisdomTree (W) stock has been outperforming the market over the past year, with CEO Jonathan Steinberg recently increasing his stake in the asset management company. Strong Performance in 2023 and 2024 In 2023, WisdomTree stock surged 27%, beating the S&P 500 index's 24% rise. The company has continued to keep pace with the index in 2024. Furthermore, on February 2, … [Read more...] about WisdomTree CEO Boosts Confidence
Forex News
Canada’s December Budget Deficit Update
Canada's budget deficit widened in December, driven by increased spending on government initiatives and public-debt charges, surpassing revenue gains by a significant margin. Fiscal Monitor Report The Department of Finance's monthly fiscal monitor publication revealed that the budget shortfall in December amounted to 4.47 billion Canadian dollars, equivalent to $3.32 billion. … [Read more...] about Canada’s December Budget Deficit Update
JPMorgan CEO Stock Sale
JPMorgan Chase & Co. CEO Jamie Dimon made his first-ever stock sale on Thursday, unloading $150 million in company shares according to a recent filing. Prior to this sale, Dimon had expressed his intention to divest stock. Sale Details Dimon sold 821,800 shares of JPMorgan at an average price of approximately $182.73. The sales were conducted through a Rule 10b5-1 trading … [Read more...] about JPMorgan CEO Stock Sale
Energy Fuels Uranium Price Surge
Energy Fuels has observed a substantial increase in uranium prices and is gearing up to produce up to half a million pounds of the concentrate utilized in nuclear fuel this year. Strong Sales Performance "In 2023, we managed to sell 560,000 pounds of uranium at an average price of $60 per pound, resulting in total gross profits of $17.96 million with an impressive 54% gross … [Read more...] about Energy Fuels Uranium Price Surge
Krystal Biotech’s Surprise Profit
Shares of Krystal Biotech saw a sharp increase when the company reported an unexpected profit in the fourth quarter. The stock surged by 13% to reach $126, following a 10% decline year-to-date prior to the latest market close. Impressive Financial Performance Krystal Biotech, a commercial-stage biotechnology company, announced a profit of $8.7 million or 30 cents per share in … [Read more...] about Krystal Biotech’s Surprise Profit
